Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Lupulone has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Beta-acids degrade through oxidation of the acylphloroglucinol core, which is why aged hops lose their beta-acid content and why hop products are stored cold and dark. A tocopherol antioxidant in an oil-based or softgel format slows that loss. This is a stability relationship in the container, not a biological interaction in the body. Without it, label content and delivered content diverge over shelf life.
Beta-acids partition into fat rather than dissolving in water, so a dry powder in a hard capsule presents a dissolution-limited absorption problem. A medium-chain triglyceride carrier keeps the compound in solution through the gut and recruits normal lipid absorption. This is formulation chemistry that applies to the whole acylphloroglucinol family, not a lupulone-specific finding.
Lecithin emulsifies poorly soluble actives into mixed micelles, increasing the surface area available at the intestinal wall. The technique is well established across lipophilic botanicals. Whether it produces a meaningful blood-level change for lupulone specifically has not been measured in people.
Hops has a traditional association with calm and sleep, and hop-plus-melatonin blends are common. The sedative-associated hop fraction is generally attributed to degradation products such as 2-methyl-3-buten-2-ol rather than to lupulone itself, so attributing this to the beta-acid overstates what is known. Anyone combining sedating agents should count the total. Read this as an additive-effect flag rather than a benefit claim.
The two herbs are combined so consistently that single-herb hop data in people is scarce. As with melatonin, the calming fraction of hops is not clearly the beta-acids, so a lupulone-specific contribution is unproven. The practical point is additive: stacking two sedating botanicals produces more sedation than either, which matters for driving and for anyone already on a sedating medication.
Beta-acids act as ionophores across the Gram-positive cell membrane, dissipating the transmembrane pH gradient. That is why hops preserve beer against lactic acid bacteria specifically. Lactobacillus and Bifidobacterium species fall in the same susceptibility class. Taking a concentrated beta-acid preparation in the same swallow as a live culture puts the two in direct contact, so spacing them is the sensible default.
Hop acids are routinely isolated and stabilised as magnesium, calcium or zinc salts precisely because they bind divalent cations well. In the gut the same chemistry can tie up a portion of a mineral dose. The industrial use of these salts is the clearest evidence that the binding is real. Separating a hop beta-acid product from mineral supplements by a couple of hours removes the overlap.
Magnesium beta-acid salts exist as products in their own right, which demonstrates the affinity directly. Where the compound is delivered as a free acid rather than a pre-formed salt, it retains the capacity to bind magnesium presented at the same time. In a pre-formed magnesium salt the interaction is already accounted for and no spacing is needed.
Prenylated hop phenolics are cleared largely by glucuronidation, and silymarin components inhibit several UGT isoforms in vitro. Whether that shifts lupulone exposure in a person has not been measured. Read this as mechanistic rather than clinical, and worth noting only where both are taken at concentrated doses.
Nothing specific on file for Lupulone. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 2 we read for Lupulone. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.